JAPANESE - Requirements for fully-integrated service-offerings in a HPAPI and cytotoxic environment

Drug-product development for highly potent APIs (HPAPIs) is challenging. This webinar provides best practices for developing and manufacturing highly potent compounds, infrastructure requirements that can facilitate development, and accelerated timelines to clinic and market. Case studies review the development, rapid scaling, and commercial production of HPAPI drug substance, as well as integrated containment requirements for particle engineering and drug product. To learn more, please view our webinar.